Research Article

Machine Learning and Computational Insights into Nanoparticle-Based Drug Delivery

Authors

  • Omar Mar Cornelio * Center for Computational Mathematics Studies, University of Computer Science, 19370 Havana, Cuba.

https://doi.org/10.48313/bic.vi.56

Abstract

Nanoparticle-based drug delivery systems have emerged as a promising strategy to overcome the limitations of conventional therapeutic approaches, including poor bioavailability, lack of target specificity, and systemic toxicity. The unique physicochemical properties of nanoparticles enable controlled drug release, enhanced targeting, and improved therapeutic efficacy. However, the design and optimization of these systems remain highly complex, requiring the integration of multiple physicochemical and biological parameters. In recent years, computational modeling and Machine Learning (ML) have gained significant attention as powerful tools to address these challenges. ML techniques facilitate the prediction of nanoparticle properties, optimization of formulation parameters, and analysis of nanoparticle–biological interactions. Moreover, data-driven approaches contribute to improved nanotoxicity assessment and more efficient drug delivery system design. This review provides a comprehensive overview of nanoparticle-based drug delivery, with a particular focus on computational methods, ML applications, available data sources, and recent case studies. Key challenges, including data scarcity, model interpretability, and reproducibility, are critically discussed. In addition, emerging trends such as personalized nanomedicine, generative artificial intelligence, and adaptive drug delivery systems are highlighted. Overall, the integration of ML with nanoparticle-based drug delivery offers a transformative pathway toward precision medicine, enabling the development of more effective, safe, and targeted therapeutic strategies.

Keywords

Nanoparticle Drug delivery Machine learning Computational modeling Nanotoxicity prediction
References (23)
  1. [1] Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016). Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chemical reviews, 116(4), 2602–2663. https://doi.org/10.1021/acs.chemrev.5b00346

  2. [2] Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018). Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: Pathways for translational development and commercialization. Frontiers in pharmacology, 9, 790. https://doi.org/10.3389/fphar.2018.00790

  3. [3] Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A., & Chen, P. (2013). Biocompatibility of engineered nanoparticles for drug delivery. Journal of controlled release, 166(2), 182–194. https://doi.org/10.1016/j.jconrel.2012.12.013

  4. [4] Bertrand, N., & Leroux, J. C. (2012). The journey of a drug-carrier in the body: An anatomo-physiological perspective. Journal of controlled release, 161(2), 152–163. https://doi.org/10.1016/j.jconrel.2011.09.098

  5. [5] Panyam, J., & Labhasetwar, V. (2012). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced drug delivery reviews, 64, 61–71. https://doi.org/10.1016/j.addr.2012.09.023

Article Metrics

How to Cite

Mar Cornelio , O. . (2026). Machine Learning and Computational Insights into Nanoparticle-Based Drug Delivery. Biocompounds, 3(1), 13-20. https://doi.org/10.48313/bic.vi.56

Similar Articles

1-10 of 43

You may also start an advanced similarity search for this article.